Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50009504
TargetNicotinamide phosphoribosyltransferase(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50453428(CHEMBL4205098)
Affinity DataIC50: 1nMAssay Description:Inhibition of full length recombinant human NAMPT using N15-NAM as substrate preincubated for 15 mins followed by substrate addition and measured aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetNicotinamide phosphoribosyltransferase(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529350(CHEMBL4546918)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of full length recombinant human NAMPT using N15-NAM as substrate preincubated for 15 mins followed by substrate addition and measured aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529356(CHEMBL4483695)
Affinity DataIC50: 3.04E+3nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529349(CHEMBL4448916)
Affinity DataIC50: 3.11E+3nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529342(CHEMBL4469631)
Affinity DataIC50: 4.69E+3nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529347(CHEMBL4586676)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529355(CHEMBL4556614)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529354(CHEMBL4441045)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529353(CHEMBL4552727)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529352(CHEMBL4456070)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529351(CHEMBL4439536)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529348(CHEMBL4532502)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529346(CHEMBL4561577)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529345(CHEMBL4575553)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529344(CHEMBL4457730)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529343(CHEMBL4571655)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529341(CHEMBL4540185)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529340(CHEMBL4541056)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529339(CHEMBL4451769)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50529338(CHEMBL4444464)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human recombinant CYP3A4 using midazolam as substrate incubated for 40 to 130 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed